本研究之目的在於調查大陸地區在禁用馬兜鈴酸藥材後的現狀調查。於2006年收集大陸各省份地區防己藥材共三十四家,以 4℃以下真空冷藏,並將樣品於前處理竭盡萃取完後入液相層析。 分析方法流程為取 1.0 g 樣品粉碎加入 200 mL甲醇溶媒,超音波震盪 30 分鐘,濾紙過濾,濃縮定量至10 mL。高效液相層析儀分析馬兜鈴酸指標成分時,移動相為CH3CN / H2O / CH3COOH (45:53:2, v/v),流速為0.8mL/min,檢測螢光波長為 254 nm。利用上述分析技術進行對照標準品馬兜鈴酸分析,結果顯示六個樣品含有馬兜鈴酸。得線性迴歸方程式(Y=mX+b)及相關係數(r)均顯示良好線性關係。同日內相對標準偏差及回收率均在可接受範圍。
The purpose of this study was to investigate the present situation of the presence of Aristolochic Acid (AA) in Fangchi or Fangji crude drugs in China after issue of a warning on AA in November 1999. All Fangchi materials were purchased from the pharmacies of Traditional Chinese Medicines in Mainland China in 2006, and a total of twelve samples were collected. All samples arrived at our laboratory frozen and were stored at ≦ 4℃ until analysed. All extracts of samples were analysed on the same day as they were prepared. The samples were analyzed by HPLC on a Thermo Electron Corporation C12 column and detected at 254 nm with acetonitrile water and 2% (v/v) acetic acid (45:55, v/v) as the mobile phase at a flow rate of 0.8 ml/min. 34 samples of commericial fangchi were analyzed and the results showed that 6 samples contained aristolochic acid I and aristolochic acid II . The content of aristolochic acid I and aristolochic acid II in sample .